A Phase Ii, Open-Label Pilot Study Evaluating The Safety And Activity Of Nal-Iri In Combination With 5-Fu And Oxaliplatin In Preoperative Treatment Of Pancreatic Adenocarcinoma (Neo-Nal-Iri Study) (Nct03483038)

Hiral D. Parekh,Jessica L. Cioffi,Kathryn Hitchcock,Ji-Hyun Lee,Z. Hugh Fan,Carmen Joseph Allegra,Steven J. Hughes,Jose Gilberto Trevino,David L. DeRemer,Thomas J. George

JOURNAL OF CLINICAL ONCOLOGY（2020）

引用 0|浏览4

暂无评分

摘要

TPS790Background: Neoadjuvant treatment for borderline resectable pancreatic cancer (PCa) is increasing in acceptability, but a standard regimen has yet to be established. Multiple studies have dem...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要